Patients with polyendocrine metabolic ovarian syndrome have higher ocular disease prevalence.
|Articles|July 15, 2003
Heidelberg Engineering VP discusses HRT work
Vista, CA-John Hawley, vice president of Heidelberg Engineering, served as an expert panelist at the Life Sciences Industry Council program, "Innovations in Eye Disease Technology," in Irvine, CA.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
One day, three approvals: FDA expands options for ocular redness, thyroid eye disease, and presbyopia
2
Duravyu misses wet AMD end point again as EyePoint pivots to DME
3
The Retina TL;DR with Dr. Weng: Thriving in fellowship with Amer Alsoudi, MD, and Monia Reding, MD
4
A vascular link: erectile dysfunction may signal glaucoma risk in men
5